TCG Crossover Management as of June 30, 2023
Portfolio Holdings for TCG Crossover Management
TCG Crossover Management holds 22 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Iveric Bio Comm | 15.8 | $96M | 2.4M | 39.34 | |
| Geron Corp Comm (GERN) | 12.4 | $76M | 24M | 3.21 | |
| Cogent Biosciences Comm (COGT) | 10.9 | $67M | 5.6M | 11.84 | |
| Vectivbio Holding Comm | 8.7 | $53M | 3.1M | 17.00 | |
| Aerovate Therapeutics Comm (AVTE) | 6.2 | $38M | 2.2M | 17.15 | |
| Icosavac Comm | 6.0 | $37M | 3.7M | 9.93 | |
| Madrigal Pharmaceuticals Comm (MDGL) | 5.7 | $35M | 150k | 231.00 | |
| Tyra Biosciences Comm (TYRA) | 5.6 | $34M | 2.0M | 17.03 | |
| Kalvista Pharmaceuticals Comm (KALV) | 5.0 | $31M | 3.4M | 9.00 | |
| Ventyx Biosciences Comm (VTYX) | 4.4 | $27M | 816k | 32.80 | |
| Dyne Therapeutics Comm (DYN) | 3.0 | $19M | 1.7M | 11.25 | |
| Kura Oncology Comm (KURA) | 2.5 | $15M | 1.4M | 10.58 | |
| Structure Therapeutics Adrs (GPCR) | 2.4 | $15M | 350k | 41.57 | |
| Immunovant Comm (IMVT) | 2.0 | $12M | 655k | 18.97 | |
| Silence Therapeutics Adrs (SLN) | 1.9 | $12M | 2.1M | 5.50 | |
| AN2 Therapeutics Comm (ANTX) | 1.8 | $11M | 1.3M | 8.50 | |
| Entrada Therapeutics Comm (TRDA) | 1.5 | $8.9M | 585k | 15.14 | |
| Merus Bv Comm (MRUS) | 1.3 | $7.9M | 300k | 26.33 | |
| Cabaletta Bio Comm (CABA) | 1.0 | $6.3M | 487k | 12.91 | |
| Aclaris Therapeutics Comm (ACRS) | 0.9 | $5.5M | 530k | 10.37 | |
| C4 Therapeutics Comm (CCCC) | 0.6 | $3.5M | 1.3M | 2.75 | |
| Alpine Immune Sciences Comm | 0.4 | $2.6M | 253k | 10.28 |
